Apnimed
Andrew Wellman, MD, PhD has a work experience that includes roles at Harvard Medical School, Apnimed, Emory University School of Medicine, and the Medical College of Georgia at Georgia Regents University. Andrew started working at Harvard Medical School in 2001 as a Physician. In 2018, they co-founded Apnimed. Prior to that, they were an Internal Medicine Resident at Emory University School of Medicine from June 1999 to May 2001. Andrew also completed an Internship at the Medical College of Georgia at Georgia Regents University from June 1998 to May 1999.
Andrew Wellman, MD, PhD, completed their Bachelor of Science in Biology, General at Presbyterian College from 1990 to 1994. Following this, they attended the Medical College of Georgia School of Medicine, where they obtained their Doctor of Medicine degree from 1994 to 1998. Finally, they pursued a Doctor of Philosophy in Bioengineering and Biomedical Engineering at the Boston University College of Engineering from 2003 to 2011.
This person is not in any offices
Apnimed
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.Sleep apnea is a common, serious condition with significant morbidity, increased mortality, and substantial effects on daily functioning. Sleep apnea affects more than 20 million Americans and has seriousconsequences. OSA is caused by a combination of predisposing anatomical factors and sleep-related decrements of activity in upper airway muscles.Current treatments primarily rely on positive pressure devices, e.g., CPAP, to maintain airway patency. Less commonly used treatments include mandibular advancement devices, nerve stimulation, and surgical interventions.Apnimed was founded in 2017 and is located in Cambridge, Massachusetts.